Skip to content

Improving the Clinical Encounter to Enhance Delivery of an Individualized Prematurity Prevention Plan

Improving the Clinical Encounter to Enhance Delivery of an Individualized Prematurity Prevention Plan (IP3) - The IMPaCT-IP3 Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04149002
Enrollment
30
Registered
2019-11-04
Start date
2020-02-01
Completion date
2021-04-01
Last updated
2022-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Birth

Brief summary

The purpose of this study is to pilot an intervention that was developed to improve uptake and adhere to an Individualized Prematurity Prevention Plan (IP3) for preterm birth prevention. Non-Hispanic Black (NHB) women are at higher risk for preterm birth compared to other racial and ethnic groups. Building on qualitative data from NHB women with input from a multidisciplinary stakeholder group, a patient-centered intervention was developed to improve uptake and adherence to an IP3 in NHB women.

Detailed description

The study team will pilot test the intervention via a pilot randomized controlled trial. 60 pregnant NHB women will be recruited who have a history of singleton preterm birth and are currently pregnant with a singleton gestation. Consenting participants will be randomized to the intervention or an active control. The intervention includes: 1) an informational narrated powerpoint presentation that reviews the logistical details of the IP3, 2) structured encouragement via text messages and 3) employment law education sheet. The powerpoints will also be available for review on our you-tube channel for intervention patients. The active control arm includes: 1) a narrated powerpoint describing the Duke Prematurity Prevention Program and 2) text messages with general pregnancy information (i.e. it is safe to take Tylenol in pregnancy). At study intake, we will collect demographic data (age, self-described race, pregnancy history, social history, pregnancy-related anxiety scale, interpersonal processes of care and maternal social support index. The team will collect feedback on the intervention based on an intake questionnaire and an exit interview. Information will also be collected on adherence to the IP3 based on review of the participant's medical record. The primary aim of the study is to evaluation feasibility and acceptability. These endpoints will be measured via enrollment and participant feedback during the exit interview.

Interventions

BEHAVIORALIntervention Arm Weekly IP3 text messages

Subjects will be provided with a pre and post intervention survey, in addition to a narrated Powerpoint presentation focusing on the logistics of their IP3. Subjects will also receive weekly automated text messages to encourage adherence to the need for their IP3.

OTHERActive Control Arm General pregnancy text messages

Subjects will be given pre and post pre questionnaires, in addition to a narrated Powerpoint presentation about the Clinic. Subjects will also be sent weekly text messages with general pregnancy information.

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Intervention Arm vs. Active Control Arm

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* self described race as Non-Hispanic Black * history of prior singleton preterm delivery (before 37 weeks gestation) * current singleton gestation

Exclusion criteria

* women with anomalous fetuses * age below 18\] * non-English speaking

Design outcomes

Primary

MeasureTime frameDescription
Feasibility as Measured by Number of Recruited Eligible Patients Enrolledstudy duration (approximately 14 months)Enrollment target of 30% of eligible patients recruited.
Acceptability as Measured by Number of Participants Who Completed the Studystudy duration (approximately 14 months)Completion target of 80% participants retained in study protocol.

Secondary

MeasureTime frameDescription
Interpersonal Process of Care (IPC-18) at Protocol Completion - Communication Domainprotocol completion (approximately 1 year)The IPC is an 18-question questionnaire that asks participants about their experience with receiving care within a specific clinic (in this case the Duke Perinatal Durham Clinic). All IPC items use an identical set of response options: 1='never'; 2='rarely'; 3='sometimes'; 4='usually'; 5='always.' Item responses are averaged, not summed; thus, scores have a possible range of 1-5. All scales are scored so that higher scores indicate higher frequency of the labeled interpersonal process: Lack of clarity (higher scores are negative), Elicits concern (higher scores are positive), and Explain results (higher scores are positive).
Interpersonal Process of Care (IPC-18) at Protocol Completion - Decision Making Domainprotocol completion (approximately 1 year)The IPC is an 18-question questionnaire that asks participants about their experience with receiving care within a specific clinic (in this case the Duke Perinatal Durham Clinic). All IPC items use an identical set of response options: 1='never'; 2='rarely'; 3='sometimes'; 4='usually'; 5='always.' Item responses are averaged, not summed; thus, scores have a possible range of 1-5. All scales are scored so that higher scores indicate higher frequency of the labeled interpersonal process: Decision Making (higher scores are positive, denoting more collaborative decision making between the clinician and patient).
Interpersonal Process of Care (IPC-18) at Protocol Completion - Interpersonal Style Domainprotocol completion (approximately 1 year)The IPC is an 18-question questionnaire that asks participants about their experience with receiving care within a specific clinic (in this case the Duke Perinatal Durham Clinic). All IPC items use an identical set of response options: 1='never'; 2='rarely'; 3='sometimes'; 4='usually'; 5='always.' Item responses are averaged, not summed; thus, scores have a possible range of 1-5. All scales are scored so that higher scores indicate higher frequency of the labeled interpersonal process: Emotional support (higher scores are positive), Discrimination due to race/ethnicity (higher scores are negative), Disrespectful to office staff (higher scores are negative).
Change in Maternal Social Support Scale (MSSS)baseline to protocol completion (approximately 1 year)The MSSS is a six-question scale that quantifies a pregnant woman's social support. Social factors (lack of family support, low friendship network, lack of help from spouse/partner, conflict with spouse/partner, feeling controlled by spouse/partner, and feeling unloved by spouse/partner) are combined in a 6-item self-report 5-point Likert scale. The total possible score for the scale is between 6 and 30, with higher scores indicating increased support.
IP3 Adherence as Measured by Number of Participants With Patient and EMR (Electronic Medical Record) Report of Medication Complianceapproximately 1 year
Birth Weight in Gramsapproximately 40 weeks
Number of Neonates Admitted to the Newborn Intensive Care Unit (NICU)approximately 40 weeks
Length of Delivery Hospital Admission in Daysapproximately 40 weeks
Gestational Age at Delivery in Weeksapproximately 40 weeks
Pregnancy Specific Anxiety (PSA)baseline, 28 weeksPregnancy specific anxiety is a 4-question scale. Each question can be answered on a range of 1 to 5. Scores were averaged to produce one mean PSA score ranging from 1-5. Higher scores are negative and denote increased anxiety.

Countries

United States

Participant flow

Participants by arm

ArmCount
Intervention Arm: Weekly IP3 Text Messages
* A narrated powerpoint presentation describing the logistical details and medical rationale for components of the IP3. Participants will view the chapters of the presentation that are relevant to their specific IP3. There are a total of 4 possible chapters (lifestyle modifications, cervix length screening/cerclage, progesterone therapy, low dose aspirin). Each chapter of the presentation is \ 10 - 15 min in length. Each chapter also includes a 4- 5 questions pre-test and the same questions are delivered as a post-test after the presentation. * Print materials including a letter explaining the importance of prenatal care for preterm birth prevention to employers. * Text messages sent weekly to encourage the patient to continue with their IP3 and provide basic pregnancy information * Formal letter of encouragement from provider at 28 weeks gestation Intervention Arm Weekly IP3 text messages: Subjects will be provided with a pre and post intervention survey, in addition to a narrated Powerpoint presentation focusing on the logistics of their IP3. Subjects will also receive weekly automated text messages to encourage adherence to the need for their IP3.
14
Control Arm: General Pregnancy Text Messages
* a pre-intervention questionnaire * a narrated powerpoint with general information about the clinic * a post-presentation questionnaire * text messages sent approximately weekly with general pregnancy information (e.g. today your baby is about the size of an apple) * an exit interview Active Control Arm General pregnancy text messages: Subjects will be given pre and post pre questionnaires, in addition to a narrated Powerpoint presentation about the Clinic. Subjects will also be sent weekly text messages with general pregnancy information.
16
Total30

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up10
Overall StudyWithdrawal by Subject10

Baseline characteristics

CharacteristicIntervention Arm: Weekly IP3 Text MessagesTotalControl Arm: General Pregnancy Text Messages
Age, Continuous30.9 years
STANDARD_DEVIATION 5.3
31.5 years
STANDARD_DEVIATION 6.2
32.1 years
STANDARD_DEVIATION 7
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
14 Participants30 Participants16 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
14 Participants30 Participants16 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
United States
14 Participants30 Participants16 Participants
Sex: Female, Male
Female
14 Participants30 Participants16 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 140 / 16
other
Total, other adverse events
0 / 140 / 16
serious
Total, serious adverse events
0 / 140 / 16

Outcome results

Primary

Acceptability as Measured by Number of Participants Who Completed the Study

Completion target of 80% participants retained in study protocol.

Time frame: study duration (approximately 14 months)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible Patients RecruitedAcceptability as Measured by Number of Participants Who Completed the Study12 Participants
Control Arm: General Pregnancy Text MessagesAcceptability as Measured by Number of Participants Who Completed the Study16 Participants
Primary

Feasibility as Measured by Number of Recruited Eligible Patients Enrolled

Enrollment target of 30% of eligible patients recruited.

Time frame: study duration (approximately 14 months)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible Patients RecruitedFeasibility as Measured by Number of Recruited Eligible Patients Enrolled30 Participants
Secondary

Birth Weight in Grams

Time frame: approximately 40 weeks

ArmMeasureValue (MEAN)Dispersion
Eligible Patients RecruitedBirth Weight in Grams2442.5 gramsStandard Deviation 1255.9
Control Arm: General Pregnancy Text MessagesBirth Weight in Grams2607.9 gramsStandard Deviation 750.6
Secondary

Change in Maternal Social Support Scale (MSSS)

The MSSS is a six-question scale that quantifies a pregnant woman's social support. Social factors (lack of family support, low friendship network, lack of help from spouse/partner, conflict with spouse/partner, feeling controlled by spouse/partner, and feeling unloved by spouse/partner) are combined in a 6-item self-report 5-point Likert scale. The total possible score for the scale is between 6 and 30, with higher scores indicating increased support.

Time frame: baseline to protocol completion (approximately 1 year)

Population: Participants who completed the MSSS questionnaire.

ArmMeasureValue (MEAN)Dispersion
Eligible Patients RecruitedChange in Maternal Social Support Scale (MSSS)0.1 score on a scaleStandard Deviation 1.5
Control Arm: General Pregnancy Text MessagesChange in Maternal Social Support Scale (MSSS)-1.4 score on a scaleStandard Deviation 2.4
Secondary

Gestational Age at Delivery in Weeks

Time frame: approximately 40 weeks

ArmMeasureValue (MEAN)Dispersion
Eligible Patients RecruitedGestational Age at Delivery in Weeks34.0 weeksStandard Deviation 6.1
Control Arm: General Pregnancy Text MessagesGestational Age at Delivery in Weeks35.7 weeksStandard Deviation 3.5
Secondary

Interpersonal Process of Care (IPC-18) at Protocol Completion - Communication Domain

The IPC is an 18-question questionnaire that asks participants about their experience with receiving care within a specific clinic (in this case the Duke Perinatal Durham Clinic). All IPC items use an identical set of response options: 1='never'; 2='rarely'; 3='sometimes'; 4='usually'; 5='always.' Item responses are averaged, not summed; thus, scores have a possible range of 1-5. All scales are scored so that higher scores indicate higher frequency of the labeled interpersonal process: Lack of clarity (higher scores are negative), Elicits concern (higher scores are positive), and Explain results (higher scores are positive).

Time frame: protocol completion (approximately 1 year)

Population: Participants who completed the IPC-18 questionnaire.

ArmMeasureGroupValue (MEAN)Dispersion
Eligible Patients RecruitedInterpersonal Process of Care (IPC-18) at Protocol Completion - Communication DomainLack of clarity1.6 score on a scaleStandard Deviation 0.6
Eligible Patients RecruitedInterpersonal Process of Care (IPC-18) at Protocol Completion - Communication DomainElicits concern4.6 score on a scaleStandard Deviation 0.6
Eligible Patients RecruitedInterpersonal Process of Care (IPC-18) at Protocol Completion - Communication DomainExplain results4.5 score on a scaleStandard Deviation 0.6
Control Arm: General Pregnancy Text MessagesInterpersonal Process of Care (IPC-18) at Protocol Completion - Communication DomainLack of clarity1.6 score on a scaleStandard Deviation 1.1
Control Arm: General Pregnancy Text MessagesInterpersonal Process of Care (IPC-18) at Protocol Completion - Communication DomainElicits concern4.7 score on a scaleStandard Deviation 0.6
Control Arm: General Pregnancy Text MessagesInterpersonal Process of Care (IPC-18) at Protocol Completion - Communication DomainExplain results4.6 score on a scaleStandard Deviation 0.7
Secondary

Interpersonal Process of Care (IPC-18) at Protocol Completion - Decision Making Domain

The IPC is an 18-question questionnaire that asks participants about their experience with receiving care within a specific clinic (in this case the Duke Perinatal Durham Clinic). All IPC items use an identical set of response options: 1='never'; 2='rarely'; 3='sometimes'; 4='usually'; 5='always.' Item responses are averaged, not summed; thus, scores have a possible range of 1-5. All scales are scored so that higher scores indicate higher frequency of the labeled interpersonal process: Decision Making (higher scores are positive, denoting more collaborative decision making between the clinician and patient).

Time frame: protocol completion (approximately 1 year)

Population: Participants who completed the IPC-18 questionnaire.

ArmMeasureValue (MEAN)Dispersion
Eligible Patients RecruitedInterpersonal Process of Care (IPC-18) at Protocol Completion - Decision Making Domain4.4 score on a scaleStandard Deviation 1.1
Control Arm: General Pregnancy Text MessagesInterpersonal Process of Care (IPC-18) at Protocol Completion - Decision Making Domain4.8 score on a scaleStandard Deviation 0.4
Secondary

Interpersonal Process of Care (IPC-18) at Protocol Completion - Interpersonal Style Domain

The IPC is an 18-question questionnaire that asks participants about their experience with receiving care within a specific clinic (in this case the Duke Perinatal Durham Clinic). All IPC items use an identical set of response options: 1='never'; 2='rarely'; 3='sometimes'; 4='usually'; 5='always.' Item responses are averaged, not summed; thus, scores have a possible range of 1-5. All scales are scored so that higher scores indicate higher frequency of the labeled interpersonal process: Emotional support (higher scores are positive), Discrimination due to race/ethnicity (higher scores are negative), Disrespectful to office staff (higher scores are negative).

Time frame: protocol completion (approximately 1 year)

Population: Participants who completed the IPC-18 questionnaire.

ArmMeasureGroupValue (MEAN)Dispersion
Eligible Patients RecruitedInterpersonal Process of Care (IPC-18) at Protocol Completion - Interpersonal Style DomainEmotional support4.7 score on a scaleStandard Deviation 0.5
Eligible Patients RecruitedInterpersonal Process of Care (IPC-18) at Protocol Completion - Interpersonal Style DomainDiscrimination due to race/ethnicity1.5 score on a scaleStandard Deviation 0.7
Eligible Patients RecruitedInterpersonal Process of Care (IPC-18) at Protocol Completion - Interpersonal Style DomainDisrespectful to office staff1.2 score on a scaleStandard Deviation 0.3
Control Arm: General Pregnancy Text MessagesInterpersonal Process of Care (IPC-18) at Protocol Completion - Interpersonal Style DomainEmotional support4.8 score on a scaleStandard Deviation 0.4
Control Arm: General Pregnancy Text MessagesInterpersonal Process of Care (IPC-18) at Protocol Completion - Interpersonal Style DomainDiscrimination due to race/ethnicity1.3 score on a scaleStandard Deviation 0.8
Control Arm: General Pregnancy Text MessagesInterpersonal Process of Care (IPC-18) at Protocol Completion - Interpersonal Style DomainDisrespectful to office staff1.1 score on a scaleStandard Deviation 0.5
Secondary

IP3 Adherence as Measured by Number of Participants With Patient and EMR (Electronic Medical Record) Report of Medication Compliance

Time frame: approximately 1 year

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eligible Patients RecruitedIP3 Adherence as Measured by Number of Participants With Patient and EMR (Electronic Medical Record) Report of Medication Compliance1 Participants
Control Arm: General Pregnancy Text MessagesIP3 Adherence as Measured by Number of Participants With Patient and EMR (Electronic Medical Record) Report of Medication Compliance3 Participants
Secondary

Length of Delivery Hospital Admission in Days

Time frame: approximately 40 weeks

ArmMeasureValue (MEDIAN)
Eligible Patients RecruitedLength of Delivery Hospital Admission in Days2 days
Control Arm: General Pregnancy Text MessagesLength of Delivery Hospital Admission in Days3 days
Secondary

Number of Neonates Admitted to the Newborn Intensive Care Unit (NICU)

Time frame: approximately 40 weeks

ArmMeasureValue (COUNT_OF_UNITS)
Eligible Patients RecruitedNumber of Neonates Admitted to the Newborn Intensive Care Unit (NICU)5 Neonates
Control Arm: General Pregnancy Text MessagesNumber of Neonates Admitted to the Newborn Intensive Care Unit (NICU)4 Neonates
Secondary

Pregnancy Specific Anxiety (PSA)

Pregnancy specific anxiety is a 4-question scale. Each question can be answered on a range of 1 to 5. Scores were averaged to produce one mean PSA score ranging from 1-5. Higher scores are negative and denote increased anxiety.

Time frame: baseline, 28 weeks

Population: Participants who completed the PSA questionnaire.

ArmMeasureGroupValue (MEAN)Dispersion
Eligible Patients RecruitedPregnancy Specific Anxiety (PSA)Baseline2.6 score on a scaleStandard Deviation 1
Eligible Patients RecruitedPregnancy Specific Anxiety (PSA)28 Weeks2.3 score on a scaleStandard Deviation 0.9
Control Arm: General Pregnancy Text MessagesPregnancy Specific Anxiety (PSA)Baseline2.4 score on a scaleStandard Deviation 0.9
Control Arm: General Pregnancy Text MessagesPregnancy Specific Anxiety (PSA)28 Weeks2.3 score on a scaleStandard Deviation 0.6

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026